NCT05260957
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- University of Miami Miami, Florida, United States
Clinical trial condition
Refractory Non-Hodgkin Lymphoma
Explore clinical trials studying Refractory Non-Hodgkin Lymphoma. Study availability and eligibility vary by location and protocol.
54 public trials
15 recruiting studies
Refractory Non-Hodgkin Lymphoma trial results
NCT06550141
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Recruiting
T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)
NCT06343311
- Conditions
- B-Cell Non-Hodgkin's Lymphoma (NHL), CNS Lymphoma, HIV Associated Lymphoma, +21 more
- Locations
-
- University of California, Davis Sacramento, California, United States
- Baylor Scott & White Research Institute, Texas Oncology Dallas, Texas, United States
NCT06119685
- Conditions
- Blood Cancer, Blood Protein Disorders, Cardiovascular Diseases, +23 more
- Locations
-
- Valkyrie Clinical Trials Los Angeles, California, United States
- Florida Cancer Specialists and Research Institute - Lake Mary Cancer Center Lake Mary, Florida, United States
- Emory University Hospital Atlanta, Georgia, United States
- University of Minnesota Minneapolis, Minnesota, United States
NCT05967416
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- City of Hope Duarte, California, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
- MD Anderson Cancer Center Houston, Texas, United States
Not Yet Recruiting
Homoharringtonine, BCL-2 Inhibitor, Rituximab, and Prednisone in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NCT07159906
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Department of Hematology, The First Affiliated Hospital, School of Medicine, Zhejiang University Hangzhou, Zhejiang, China
Not Yet Recruiting
First in Human Study of the Infusion of ARI0003 Cells in Relapsed/Refractory to Treatment B-cell Aggressive Lymphoma
NCT06097455
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- CHU Santiago de Compostela Santiago de Compostela, A Coruña, Spain
- Hospital Clínic Barcelona Barcelona, Spain
- H. Ramon y Cajal Madrid, Spain
- H.U. Virgen de la Arrixaca Murcia, Spain
NCT04205409
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +46 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
CAR-T for R/R B-NHL
NCT03196830
- Conditions
- CAR - T CD19/CD20/CD22/CD30, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
- Locations
-
- the First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
NCT04923789
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China